We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,095

GAO Releases Report Analyzing HHS-OIG Integrity Agreements Since 2005
  • Cooley LLP
  • USA
  • May 16 2018

The U.S. Government Accountability Office (GAO) released a report on May 10th characterizing over 10 years of corporate integrity agreements and


Hospitals Face Sizable Overpayment Liability for Not Reporting Medical Device Credits
  • Nelson Mullins Riley & Scarborough LLP
  • USA
  • April 9 2018

The Office of Inspector General (OIG) continues to unearth widespread noncompliance by hospitals with requirements for reporting the receipt of


YLD Health Law Committee - Winter 2018
  • Breazeale Sachse & Wilson LLP
  • USA
  • March 26 2018

Few things can ruin a day faster than having a federal investigative agent show up at the door. In the current climate in which the government


Second Circuit finds government's continued payment in face of fraud allegations undercuts materiality
  • Sidley Austin LLP
  • USA
  • January 31 2018

In Universal Health Services v United States ex rel Escobar the Supreme Court emphasised that questions of materiality are not "too fact


DOJ Limits the Use of Agencies' Guidance Documents in Civil Enforcement Actions
  • Jones Day
  • USA
  • January 31 2018

The Department of Justice ("DOJ") recently issued a memorandum limiting the ability of its litigators to use agency guidance documents in civil


As Congress Struggles With ACA Repeal, Trump Administration Moves Forward With Regulatory Reform
  • Skadden Arps Slate Meagher & Flom LLP
  • USA
  • January 23 2018

The Trump administration and Republican-led Congress spent substantial time and political capital in 2017 on efforts to repeal and replace the


Second Circuit Finds That The Government’s Continued Payment In The Face of Fraud Allegations Undercuts Materiality
  • Sidley Austin LLP
  • USA
  • January 2 2018

The Supreme Court emphasized in Escobar that questions of materiality are not "too fact intensive for courts" to decide through a motion to dismiss


Fraud on the FDA? If Not Preempted, It Is Trumpery
  • Reed Smith LLP
  • USA
  • October 2 2017

With Bexis having originally conceived the preemption argument that became Buckman Co. v. Plaintiffs Legal Committee, 531 U.S. 341 (2001), we are


Escobar's Effect on False Claims Act Qui Tam Actions
  • Dinsmore & Shohl LLP
  • USA
  • October 2 2017

The False Claims Act (FCA or Act) can be a real punch in the gut for businesses on the wrong side of an FCA claim. The Act, codified at 31 U.S.C


How Companies Should Prep for Enforcement Shift to State AGs
  • Foley & Lardner LLP
  • USA
  • August 23 2017

“Top Cop” is how every state Attorney General wants to be known. In reality, state AGs have far more authority for civil enforcement than they do for